Fri, Sep 19, 2014, 11:06 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Celsion Corp. Message Board

  • jasonrobinson220 jasonrobinson220 Dec 6, 2012 8:17 PM Flag

    Why is this stock still trading so low ?

    if you compare market cap between CLSN and DNDN than clsn would be $2.75 Roughly (DNDN) markets cap its over 700 million CLSN is 260 billion.

    Another similiar stock is EXEL, their market cap is almost trading at 800 Billion. It was higher until they got their fda approval (strange)

    If clsn were trading where exel was trading prior to fda approval or even third trial, the price would be almost $22.00 a shares, instead its $7.45

    Both DNDN and EXEL are trading lower than clsn but if you compare it to their market caps they are way higher.

    Do people just not realize this? Do people think its trading high when really its trading really low in compairson to similiar biotechs?

    Management has postponed dilution until after the trial results, so these small amount of shares should be worth more than 260 Billion in my opinion.

    CLSN's product blow both these companies away in terms of market value

    Please help me figure this out to whomever as any opinions

    Sentiment: Strong Buy

3.03-0.05(-1.62%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.